On the Persistence of an Oily Contrast Medium (Lipiodol Ultrafluid (R)) in Normal and Abnormal Lymph Nodes

  • H.-J. Teske
  • B. Kalkowsky


Patients having undergone lymphography who were followed up for a period of several years by x-ray controls showed marked differences in the decreasing rate of contrast medium (c.m.) according to time. There are few and contradictory reports in the literature on factors influencing the decrease of stored c.m.: Ruttiman found visible cm. in lymph nodes (l.n.) up to 4–10 months. In normal nodes Viamonte observed the disappearance of the oily medium within 1–3 months. Abnormal nodes on the other hand retained the contrast material sometimes for years. In nodes with active inflammation Viamonte noticed disappearance within 48 hours. According to Fabion the c.m. persisted in the nodes for 5 to 34 months; 70% of the patients had c.m. sufficient for diagnosis at the end of 1 year, while in 12% it was still visible at the end of 2 years. Abnormal l.n. are thought to have a greater tendency to store than normal ones (Blaudow; Viamonte). There is however little information on the following factors: age, sex or mode of therapy.


Contrast Medium Malignant Lymphoma Normal Person Normal Node Active Inflammation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Blaudow, K. and Banaschek, A.: Die Bedeutung der Lymphographie für gynakologische Karzinome. Radiol. diagn. (Berl.) 9 (1968), 661–668.Google Scholar
  2. 2.
    Fabion, C.E., Nudelmann, E.J. and Abrahams, H.L.: Postlymph-angiogram film as an indicator of tumor activity. Invest. Radiol, 1 (1966), 386–398.CrossRefGoogle Scholar
  3. 3.
    Gerteis, W.: In: Handb. allg. Pathol. Springer, Berlin-Heidelberg-New York 1972, Bd 3, Teil 6, S. 595-656. Darstellungsmethoden des Lymphagefabsystems and praktische Lymphographie.Google Scholar
  4. 4.
    Teske, H.-J., Heissen, E., and Haller, J.: Lymphographische Verlaufskontrollen bei lymphatischen Systemerkrankungen. Munch. med. Wschr. 112 (1970), 1309–1316.PubMedGoogle Scholar
  5. 5.
    Viamonte, M.: In: Progress in Lymphology I. Thieme, Stuttgart 1967, page 168.Google Scholar
  6. 6.
    Weissleder, H., Renemann, H., and Baumeister, L.: Der diagnostische Wert lymphografischen Verlaufskontrollen. Fortschr. Rontgenstr. 104 (1966), 14–22.CrossRefGoogle Scholar
  7. 7.
    Ruttimann, A., Del Buono, M.S.: In: Ergebnisse der medizinischen Strahlenforschung. Springer, Berlin-Heidelberg-New York 1964, Bd. I, S.248–318, Die Lymphographie.Google Scholar

Copyright information

© Plenum Press, New York 1977

Authors and Affiliations

  • H.-J. Teske
    • 1
  • B. Kalkowsky
    • 1
  1. 1.Universtate-StrahlenklinikHufelandstra, 55West Germany

Personalised recommendations